Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Neoplasms

Explore clinical trials studying Central Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

535 public trials 57 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Neoplasms trial results

Active, not recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

NCT05599984

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +20 more
Locations
  • Banner MD Anderson Cancer Ctr /ID# 260129 Gilbert, Arizona, United States
  • City Of Hope Comprehensive Cancer Center /ID# 271295 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 259884 Irvine, California, United States
  • Yale New Haven Hospital /ID# 246647 New Haven, Connecticut, United States
View all 66 locations
View Trial Details
Active, not recruiting

Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

NCT05081180

Conditions
Central Nervous System Neoplasms, Central Nervous System Tumors, Neoplasms, +3 more
Locations
  • CHU Sainte-Justine Montreal, Canada
  • The Hospital for Sick Children Toronto, Canada
  • CHU Angers - Hôpital Hôtel Dieu - Service de Cancérologie Pédiatrique Angers, France
  • Hôpital de la Timone Marseille, France
View Trial Details
Active, not recruiting

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

NCT03157128

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Any Solid Tumor, +46 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 85 locations
View Trial Details
Active, not recruiting

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

NCT00887146

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 291 locations
View Trial Details
Active, not recruiting

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

NCT03899792

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more
Locations
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • The Children's Hospital for Cancer and Blood Disorders Aurora, Colorado, United States
  • Nemours Children's Health Orlando, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Active, not recruiting

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

NCT02932280

Conditions
Central Nervous System Neoplasms, Central Nervous System Tumor, Disease, +18 more
Locations
  • Phoenix Children'S Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University School of Medicine and Stanford Cancer Institute Palo Alto, California, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View Trial Details
Active, not recruiting

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

NCT03834961

Conditions
Central Nervous System Neoplasm, Central Nervous System Neoplasms, Infantile Fibrosarcoma, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 80 locations
View Trial Details
Active, not recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

NCT04446962

Conditions
Central Nervous System Neoplasms, Central Nervous System Neoplasms, Primary, Hemic and Lymphatic Diseases, +16 more
Locations
  • CHU Amiens Amiens, France
  • CHU Angers Angers, France
  • CH côte Basque Bayonne, France
  • CHU Besançon Besançon, France
View all 28 locations
View Trial Details

Related conditions